Hypersensitivity reactions occur when the immune system mounts an excessive or inappropriate immune response against substances that are normally considered harmless. This document discusses the classification and mechanisms of different types of hypersensitivity reactions. Type II hypersensitivity reactions involve cell-bound antibodies activating the complement system, leading to lysis of cells bearing the antigen. Diseases associated with type II reactions include blood transfusion reactions, hemolytic disease of the newborn, autoimmune hemolytic anemia, and certain autoimmune diseases.
This document discusses the different types of hypersensitivity reactions. It begins by defining hypersensitivity and describing the two categories of adaptive hypersensitivity: immediate and delayed. It then outlines Coomb and Gell's 1963 classification of hypersensitivity reactions into four main types (I-IV) based on mechanism and time course. The bulk of the document describes Type I (IgE-mediated) hypersensitivity in detail, covering characteristics, mechanisms, effects, examples in humans and animals. It also discusses Type II (antibody-mediated cytotoxic), Type III (immune complex-mediated), and introduces Type IV (cell-mediated) hypersensitivity.
This document discusses allergy and hypersensitivity reactions. It defines allergy as a type I hypersensitivity reaction mediated by IgE antibodies. There are four types of hypersensitivity reactions classified based on the immune mechanisms involved and time taken for the reaction. Type I reactions are immediate and anaphylactic, type II are cytotoxic, type III involve immune complexes, and type IV are cell-mediated or delayed hypersensitivity reactions. The document provides details on the pathophysiology, clinical manifestations, diagnosis and treatment of each type of hypersensitivity reaction.
This document discusses allergy and hypersensitivity, specifically focusing on the four types of hypersensitivity reactions. Type I is an immediate or anaphylactic reaction mediated by IgE antibodies and mast cells, causing issues like anaphylaxis. Type II involves IgG/IgM antibodies attacking cells, type III involves immune complex formation and complement activation. Type IV is a delayed hypersensitivity reaction involving T cells and macrophages forming granulomas. The mechanisms, signs and symptoms, and treatments of each type are described.
This document discusses different types of hypersensitivity reactions and allergies. It describes 4 types of hypersensitivity reactions:
Type I is an immediate or anaphylactic reaction mediated by IgE antibodies and mast cells. Type II involves antibody-dependent cytotoxic reactions mediated by IgG and IgM antibodies. Type III reactions are immune complex-mediated responses. Type IV is a cell-mediated reaction involving T cells. The document provides details on the mechanisms, mediators, symptoms and treatments for each type of hypersensitivity reaction.
Hypersensitivity is an excessive immune response that leads to undesirable tissue or organ damage and dysfunction. There are four main types: type I is antibody-mediated and involves IgE, type II also involves antibodies and can cause hemolysis, type III involves immune complex deposition and complement activation, and type IV is T-cell mediated and causes delayed hypersensitivity reactions. Therapy for type I hypersensitivity focuses on allergen avoidance, desensitization treatments, and drugs like antihistamines and adrenaline.
Hypersensitivity Update .pdf Immunology and Microosmanolow
Immunology is the study of the immune system and is a very important branch of the medical and biological sciences. The immune system protects us from infection through various lines of defence.
Hypersensitivity. immunology and microbiology coursemulkiabdiadan
This document discusses the four main types of hypersensitivity reactions:
1. Type I is an immediate hypersensitivity mediated by IgE antibodies. It causes rapid allergic reactions.
2. Type II involves antibody-mediated cytotoxicity, where antibodies bind to antigens on cell surfaces and activate the complement system or promote phagocytosis.
3. Type III hypersensitivity is caused by immune complex deposition, where circulating antigen-antibody complexes activate the complement system and cause inflammation.
4. Type IV is a delayed hypersensitivity mediated by T cells and macrophages. It causes inflammatory responses 12-72 hours after antigen exposure and is involved in many autoimmune and infectious diseases.
This document discusses the four types of hypersensitivity reactions classified by Gell and Coombs: Type I (IgE-mediated), Type II (antibody-mediated cytotoxicity), Type III (immune complex-mediated), and Type IV (T cell-mediated delayed hypersensitivity). It provides details on the pathophysiology, mechanisms of tissue damage, examples of diseases, and characteristics of each type of hypersensitivity reaction.
This document discusses the different types of hypersensitivity reactions. It begins by defining hypersensitivity and describing the two categories of adaptive hypersensitivity: immediate and delayed. It then outlines Coomb and Gell's 1963 classification of hypersensitivity reactions into four main types (I-IV) based on mechanism and time course. The bulk of the document describes Type I (IgE-mediated) hypersensitivity in detail, covering characteristics, mechanisms, effects, examples in humans and animals. It also discusses Type II (antibody-mediated cytotoxic), Type III (immune complex-mediated), and introduces Type IV (cell-mediated) hypersensitivity.
This document discusses allergy and hypersensitivity reactions. It defines allergy as a type I hypersensitivity reaction mediated by IgE antibodies. There are four types of hypersensitivity reactions classified based on the immune mechanisms involved and time taken for the reaction. Type I reactions are immediate and anaphylactic, type II are cytotoxic, type III involve immune complexes, and type IV are cell-mediated or delayed hypersensitivity reactions. The document provides details on the pathophysiology, clinical manifestations, diagnosis and treatment of each type of hypersensitivity reaction.
This document discusses allergy and hypersensitivity, specifically focusing on the four types of hypersensitivity reactions. Type I is an immediate or anaphylactic reaction mediated by IgE antibodies and mast cells, causing issues like anaphylaxis. Type II involves IgG/IgM antibodies attacking cells, type III involves immune complex formation and complement activation. Type IV is a delayed hypersensitivity reaction involving T cells and macrophages forming granulomas. The mechanisms, signs and symptoms, and treatments of each type are described.
This document discusses different types of hypersensitivity reactions and allergies. It describes 4 types of hypersensitivity reactions:
Type I is an immediate or anaphylactic reaction mediated by IgE antibodies and mast cells. Type II involves antibody-dependent cytotoxic reactions mediated by IgG and IgM antibodies. Type III reactions are immune complex-mediated responses. Type IV is a cell-mediated reaction involving T cells. The document provides details on the mechanisms, mediators, symptoms and treatments for each type of hypersensitivity reaction.
Hypersensitivity is an excessive immune response that leads to undesirable tissue or organ damage and dysfunction. There are four main types: type I is antibody-mediated and involves IgE, type II also involves antibodies and can cause hemolysis, type III involves immune complex deposition and complement activation, and type IV is T-cell mediated and causes delayed hypersensitivity reactions. Therapy for type I hypersensitivity focuses on allergen avoidance, desensitization treatments, and drugs like antihistamines and adrenaline.
Hypersensitivity Update .pdf Immunology and Microosmanolow
Immunology is the study of the immune system and is a very important branch of the medical and biological sciences. The immune system protects us from infection through various lines of defence.
Hypersensitivity. immunology and microbiology coursemulkiabdiadan
This document discusses the four main types of hypersensitivity reactions:
1. Type I is an immediate hypersensitivity mediated by IgE antibodies. It causes rapid allergic reactions.
2. Type II involves antibody-mediated cytotoxicity, where antibodies bind to antigens on cell surfaces and activate the complement system or promote phagocytosis.
3. Type III hypersensitivity is caused by immune complex deposition, where circulating antigen-antibody complexes activate the complement system and cause inflammation.
4. Type IV is a delayed hypersensitivity mediated by T cells and macrophages. It causes inflammatory responses 12-72 hours after antigen exposure and is involved in many autoimmune and infectious diseases.
This document discusses the four types of hypersensitivity reactions classified by Gell and Coombs: Type I (IgE-mediated), Type II (antibody-mediated cytotoxicity), Type III (immune complex-mediated), and Type IV (T cell-mediated delayed hypersensitivity). It provides details on the pathophysiology, mechanisms of tissue damage, examples of diseases, and characteristics of each type of hypersensitivity reaction.
I) Type II hypersensitivity reactions, also known as cytotoxic reactions, involve antibody-mediated destruction of cells through two main mechanisms:
1) Activation of the complement system leads to pore formation and lysis of the target cell.
2) Antibody-dependent cell-mediated cytotoxicity (ADCC) occurs when antibodies bind to target cells and recruit natural killer cells or macrophages to destroy the target cell.
Some examples of type II hypersensitivity reactions include hemolytic anemia caused by antibodies against blood cells, transfusion reactions due to ABO incompatibility, and hemolytic disease of the newborn from Rh incompatibility.
Type I, II, III, and IV hypersensitivity reactions are classified based on their pathogenic mechanisms. Type I reactions involve IgE antibodies and mast cell degranulation. Type II reactions involve IgG or IgM antibodies binding to cell surfaces and activating complement. Type III reactions involve immune complex deposition in tissues. Type IV reactions are T cell-mediated and occur hours to days after antigen exposure. Examples of each type are discussed.
This document discusses the different types of hypersensitivity reactions:
Type I reactions are immediate and anaphylactic, mediated by IgE antibodies binding to mast cells. Type II reactions are cytotoxic and antibody-mediated, directly damaging cells. Type III reactions involve immune complex deposition causing inflammation. Type IV reactions are delayed and T cell-mediated, causing localized reactions where antigen is present. The types are distinguished by the mechanisms and timescales involved. Hypersensitivity reactions can cause issues in various tissues and organs.
This document discusses different types of immune disorders including immunodeficiency, hypersensitivity, and autoimmunity. It provides details on the classification and mechanisms of four types of hypersensitivity reactions (type I-IV). Type I reactions are immediate and antigen-specific IgE mediated. Type II involve IgG and IgM antibodies against antigens on cells. Type III are caused by immune complex deposition. Type IV are cell-mediated and involve sensitized T cells rather than antibodies.
This document summarizes the four main types of hypersensitivity reactions: Type I (immediate or anaphylactic), Type II (antibody-dependent cytotoxic), Type III (complex-mediated), and Type IV (cell-mediated or delayed). It provides details on the mechanisms, examples, diagnostic tests and treatments for each type of hypersensitivity reaction.
The document summarizes different types of hypersensitivity reactions:
Type I reactions are immediate and mediated by IgE antibodies. They cause conditions like allergic rhinitis and anaphylaxis. Type II reactions are caused by IgG and IgM antibodies binding to cells, activating complement and causing cell lysis. Type III reactions involve immune complexes forming in circulation and depositing in tissues, activating complement and causing damage. Type IV reactions are cell-mediated, initiated by sensitized T cells, and cause delayed hypersensitivity responses and cytotoxic killing of infected cells.
Type I hypersensitivity, also known as immediate hypersensitivity or allergy, is an IgE-mediated immune response. Upon re-exposure to an allergen, IgE antibodies bound to mast cells and basophils are cross-linked, causing the release of inflammatory mediators like histamine. This leads to symptoms of allergy such as sneezing, itching, and difficulty breathing. Allergies can be localized to specific organs like the skin or lungs, or can cause systemic anaphylaxis with a dangerous drop in blood pressure.
Type I hypersensitivity reactions are immediate and IgE-mediated, causing conditions like anaphylaxis, allergic rhinitis, asthma, and food allergies. Type II reactions are cytotoxic and IgG/IgM-mediated, damaging cells and causing immune thrombocytopenia, hemolytic anemia, and erythroblastosis fetalis. Type III reactions involve immune complex formation and complement activation, seen in serum sickness and Arthus reaction. Type IV reactions are cell-mediated and CD4/CD8 T-cell mediated, causing delayed hypersensitivity conditions like contact dermatitis.
Hypersensitivity reactions are immune responses that are harmful or unpleasant for the host. There are four main types of hypersensitivity reactions classified based on the mechanisms involved:
Type I reactions are immediate and mediated by IgE antibodies binding to mast cells. Common examples include allergic rhinitis and anaphylaxis.
Type II reactions are cytotoxic and involve IgG or IgM binding to cell surfaces and activating the complement system. Examples include blood transfusion reactions and hemolytic disease of the newborn.
Type III reactions are immune complex-mediated where circulating immune complexes deposit in tissues, activating the complement system and causing inflammation. Examples include serum sickness and hypersensitivity pneumonitis.
Type IV reactions are delayed and
The document discusses hypersensitivity and the four types of hypersensitivity reactions classified by Gell and Coombs. Type I reactions are immediate and antigen-specific IgE mediated responses. Type I hypersensitivity involves mast cell degranulation and release of inflammatory mediators, causing allergic reactions like hay fever. Type II reactions involve IgG or IgM binding to cell surfaces or extracellular antigens, activating complement and destroying cells through lysis or phagocytosis. An example is ABO blood type incompatibility.
Dr. ihsan edan abdulkareem alsaimary
PROFESSOR IN MEDICAL MICROBIOLOGY AND MOLECULAR IMMUNOLOGY
ihsanalsaimary@gmail.com
mobile : 009647801410838
university of basrah - college of medicine - basrah -IRAQ
This document discusses types of hypersensitivity reactions and autoimmunity. It describes 4 types of hypersensitivity reactions:
1) Type I reactions are IgE-mediated and involve mast cells/basophils, causing immediate reactions like anaphylaxis.
2) Type II reactions involve IgG/IgM antibodies binding to cell surfaces and activating complement, resulting in cell lysis.
3) Type III reactions occur when antigen-antibody complexes deposit in tissues, triggering inflammatory responses like serum sickness.
4) Type IV reactions are cell-mediated and involve T cells/macrophages, causing delayed responses like contact dermatitis.
The document also discusses mechanisms of immunological tolerance that
This document discusses the different types of hypersensitivity reactions:
I) Immediate hypersensitivity is mediated by IgE antibodies binding to mast cells and basophils, triggering the release of inflammatory mediators that cause rapid allergic reactions.
II) Antibody-mediated hypersensitivity occurs when antibodies bind to cells and tissues, leading to phagocytosis, complement activation, inflammation and cell/tissue damage.
III) Immune complex-mediated hypersensitivity is caused by the deposition of antigen-antibody complexes in tissues, which activates the complement system and recruits inflammatory cells, resulting in conditions like vasculitis and glomerulonephritis.
IV) Cell-mediated hypersensitivity is a T cell
Type I hypersensitivity, also known as immediate hypersensitivity, is an exaggerated immune response mediated by IgE antibodies. It causes allergic reactions and is triggered by exposure to common allergens like pollen, dust mites, animal dander, etc. Type IV hypersensitivity is a delayed cell-mediated response that occurs 48-72 hours after exposure and is characterized by induration and erythema, as seen in tuberculin skin tests. HIV attacks CD4 T cells, weakening the immune system and leaving the body vulnerable to opportunistic infections. If untreated, HIV develops into AIDS, defined by a CD4 count below 200 or the presence of AIDS-defining illnesses.
The 12-year-old boy was stung by a bee and began experiencing symptoms of anaphylaxis including shortness of breath, wheezing, weakness, and dizziness. At the emergency department, he was found to have low blood pressure, rapid heart rate, respiratory distress, urticaria, and pale appearance. He was treated with epinephrine, antihistamines, steroids, and fluids, which resolved his symptoms. He was discharged with oral medications and instructed to follow up. Anaphylaxis is a severe, potentially life-threatening allergic reaction caused by the release of chemicals from mast cells and basophils.
The document summarizes the four main types of hypersensitivity reactions: Type I, II, III, and IV. Type I reactions are immediate and anaphylactic, mediated by IgE antibodies binding to allergens and crosslinking mast cells and basophils to release inflammatory mediators. Type II reactions are cytotoxic and involve IgG/IgM antibodies binding cell surfaces and activating complement-mediated cell lysis. Type III reactions occur when circulating antigen-antibody complexes are deposited in tissues, triggering inflammatory responses. Type IV reactions are cell-mediated and do not involve antibodies.
Type I hypersensitivity reactions, also known as immediate hypersensitivity reactions, are mediated by IgE antibodies. Upon re-exposure to an allergen, IgE antibodies bound to mast cells and basophils trigger the release of inflammatory mediators such as histamine. This leads to symptoms of allergy such as sneezing, itching, and potentially life-threatening anaphylaxis. Diagnosis involves skin prick tests and measuring allergen-specific IgE levels through blood tests. Repeated allergen exposure drives the sensitization process and production of more IgE antibodies in atopic individuals.
Hypersensitivity and Allergy
There are four main types of hypersensitivity reactions:
1. Type 1 is an IgE-mediated allergy involving mast cell degranulation. Common allergies include hay fever, food allergies, and more.
2. Type 2 involves IgG and IgM antibodies binding to cell surfaces and activating the complement system or phagocytes. This includes hemolytic transfusion reactions and hemolytic disease of the newborn.
3. Type 3 occurs when circulating immune complexes are deposited in tissues, activating the complement system and causing inflammation. Examples include serum sickness and some autoimmune diseases.
4. Type 4 is a delayed T cell-mediated response, like contact dermatitis and
This document discusses hypersensitivity reactions of types I and II. It defines hypersensitivity as undesirable immune responses that can cause tissue damage or death. Type I reactions are immediate and IgE-mediated, involving mast cell degranulation. Common allergens are listed. Type II reactions are antibody-mediated and cytotoxic, destroying cells through complement activation or antibody-dependent cellular cytotoxicity. Examples given include blood transfusion reactions and hemolytic disease of the newborn. The mechanisms, mediators, treatments, and tests related to types I and II hypersensitivity reactions are described in detail.
This document discusses hypersensitivity reactions of types I and II. It defines hypersensitivity as undesirable immune responses that can cause tissue damage or death. Type I reactions are immediate and IgE-mediated, involving mast cell degranulation. Common allergens are listed. Type II reactions are antibody-mediated and cytotoxic, destroying cells through complement activation or antibody-dependent cellular cytotoxicity. Examples given include blood transfusion reactions and hemolytic disease of the newborn. The mechanisms, mediators, treatments, and tests related to types I and II hypersensitivity are described in detail.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
I) Type II hypersensitivity reactions, also known as cytotoxic reactions, involve antibody-mediated destruction of cells through two main mechanisms:
1) Activation of the complement system leads to pore formation and lysis of the target cell.
2) Antibody-dependent cell-mediated cytotoxicity (ADCC) occurs when antibodies bind to target cells and recruit natural killer cells or macrophages to destroy the target cell.
Some examples of type II hypersensitivity reactions include hemolytic anemia caused by antibodies against blood cells, transfusion reactions due to ABO incompatibility, and hemolytic disease of the newborn from Rh incompatibility.
Type I, II, III, and IV hypersensitivity reactions are classified based on their pathogenic mechanisms. Type I reactions involve IgE antibodies and mast cell degranulation. Type II reactions involve IgG or IgM antibodies binding to cell surfaces and activating complement. Type III reactions involve immune complex deposition in tissues. Type IV reactions are T cell-mediated and occur hours to days after antigen exposure. Examples of each type are discussed.
This document discusses the different types of hypersensitivity reactions:
Type I reactions are immediate and anaphylactic, mediated by IgE antibodies binding to mast cells. Type II reactions are cytotoxic and antibody-mediated, directly damaging cells. Type III reactions involve immune complex deposition causing inflammation. Type IV reactions are delayed and T cell-mediated, causing localized reactions where antigen is present. The types are distinguished by the mechanisms and timescales involved. Hypersensitivity reactions can cause issues in various tissues and organs.
This document discusses different types of immune disorders including immunodeficiency, hypersensitivity, and autoimmunity. It provides details on the classification and mechanisms of four types of hypersensitivity reactions (type I-IV). Type I reactions are immediate and antigen-specific IgE mediated. Type II involve IgG and IgM antibodies against antigens on cells. Type III are caused by immune complex deposition. Type IV are cell-mediated and involve sensitized T cells rather than antibodies.
This document summarizes the four main types of hypersensitivity reactions: Type I (immediate or anaphylactic), Type II (antibody-dependent cytotoxic), Type III (complex-mediated), and Type IV (cell-mediated or delayed). It provides details on the mechanisms, examples, diagnostic tests and treatments for each type of hypersensitivity reaction.
The document summarizes different types of hypersensitivity reactions:
Type I reactions are immediate and mediated by IgE antibodies. They cause conditions like allergic rhinitis and anaphylaxis. Type II reactions are caused by IgG and IgM antibodies binding to cells, activating complement and causing cell lysis. Type III reactions involve immune complexes forming in circulation and depositing in tissues, activating complement and causing damage. Type IV reactions are cell-mediated, initiated by sensitized T cells, and cause delayed hypersensitivity responses and cytotoxic killing of infected cells.
Type I hypersensitivity, also known as immediate hypersensitivity or allergy, is an IgE-mediated immune response. Upon re-exposure to an allergen, IgE antibodies bound to mast cells and basophils are cross-linked, causing the release of inflammatory mediators like histamine. This leads to symptoms of allergy such as sneezing, itching, and difficulty breathing. Allergies can be localized to specific organs like the skin or lungs, or can cause systemic anaphylaxis with a dangerous drop in blood pressure.
Type I hypersensitivity reactions are immediate and IgE-mediated, causing conditions like anaphylaxis, allergic rhinitis, asthma, and food allergies. Type II reactions are cytotoxic and IgG/IgM-mediated, damaging cells and causing immune thrombocytopenia, hemolytic anemia, and erythroblastosis fetalis. Type III reactions involve immune complex formation and complement activation, seen in serum sickness and Arthus reaction. Type IV reactions are cell-mediated and CD4/CD8 T-cell mediated, causing delayed hypersensitivity conditions like contact dermatitis.
Hypersensitivity reactions are immune responses that are harmful or unpleasant for the host. There are four main types of hypersensitivity reactions classified based on the mechanisms involved:
Type I reactions are immediate and mediated by IgE antibodies binding to mast cells. Common examples include allergic rhinitis and anaphylaxis.
Type II reactions are cytotoxic and involve IgG or IgM binding to cell surfaces and activating the complement system. Examples include blood transfusion reactions and hemolytic disease of the newborn.
Type III reactions are immune complex-mediated where circulating immune complexes deposit in tissues, activating the complement system and causing inflammation. Examples include serum sickness and hypersensitivity pneumonitis.
Type IV reactions are delayed and
The document discusses hypersensitivity and the four types of hypersensitivity reactions classified by Gell and Coombs. Type I reactions are immediate and antigen-specific IgE mediated responses. Type I hypersensitivity involves mast cell degranulation and release of inflammatory mediators, causing allergic reactions like hay fever. Type II reactions involve IgG or IgM binding to cell surfaces or extracellular antigens, activating complement and destroying cells through lysis or phagocytosis. An example is ABO blood type incompatibility.
Dr. ihsan edan abdulkareem alsaimary
PROFESSOR IN MEDICAL MICROBIOLOGY AND MOLECULAR IMMUNOLOGY
ihsanalsaimary@gmail.com
mobile : 009647801410838
university of basrah - college of medicine - basrah -IRAQ
This document discusses types of hypersensitivity reactions and autoimmunity. It describes 4 types of hypersensitivity reactions:
1) Type I reactions are IgE-mediated and involve mast cells/basophils, causing immediate reactions like anaphylaxis.
2) Type II reactions involve IgG/IgM antibodies binding to cell surfaces and activating complement, resulting in cell lysis.
3) Type III reactions occur when antigen-antibody complexes deposit in tissues, triggering inflammatory responses like serum sickness.
4) Type IV reactions are cell-mediated and involve T cells/macrophages, causing delayed responses like contact dermatitis.
The document also discusses mechanisms of immunological tolerance that
This document discusses the different types of hypersensitivity reactions:
I) Immediate hypersensitivity is mediated by IgE antibodies binding to mast cells and basophils, triggering the release of inflammatory mediators that cause rapid allergic reactions.
II) Antibody-mediated hypersensitivity occurs when antibodies bind to cells and tissues, leading to phagocytosis, complement activation, inflammation and cell/tissue damage.
III) Immune complex-mediated hypersensitivity is caused by the deposition of antigen-antibody complexes in tissues, which activates the complement system and recruits inflammatory cells, resulting in conditions like vasculitis and glomerulonephritis.
IV) Cell-mediated hypersensitivity is a T cell
Type I hypersensitivity, also known as immediate hypersensitivity, is an exaggerated immune response mediated by IgE antibodies. It causes allergic reactions and is triggered by exposure to common allergens like pollen, dust mites, animal dander, etc. Type IV hypersensitivity is a delayed cell-mediated response that occurs 48-72 hours after exposure and is characterized by induration and erythema, as seen in tuberculin skin tests. HIV attacks CD4 T cells, weakening the immune system and leaving the body vulnerable to opportunistic infections. If untreated, HIV develops into AIDS, defined by a CD4 count below 200 or the presence of AIDS-defining illnesses.
The 12-year-old boy was stung by a bee and began experiencing symptoms of anaphylaxis including shortness of breath, wheezing, weakness, and dizziness. At the emergency department, he was found to have low blood pressure, rapid heart rate, respiratory distress, urticaria, and pale appearance. He was treated with epinephrine, antihistamines, steroids, and fluids, which resolved his symptoms. He was discharged with oral medications and instructed to follow up. Anaphylaxis is a severe, potentially life-threatening allergic reaction caused by the release of chemicals from mast cells and basophils.
The document summarizes the four main types of hypersensitivity reactions: Type I, II, III, and IV. Type I reactions are immediate and anaphylactic, mediated by IgE antibodies binding to allergens and crosslinking mast cells and basophils to release inflammatory mediators. Type II reactions are cytotoxic and involve IgG/IgM antibodies binding cell surfaces and activating complement-mediated cell lysis. Type III reactions occur when circulating antigen-antibody complexes are deposited in tissues, triggering inflammatory responses. Type IV reactions are cell-mediated and do not involve antibodies.
Type I hypersensitivity reactions, also known as immediate hypersensitivity reactions, are mediated by IgE antibodies. Upon re-exposure to an allergen, IgE antibodies bound to mast cells and basophils trigger the release of inflammatory mediators such as histamine. This leads to symptoms of allergy such as sneezing, itching, and potentially life-threatening anaphylaxis. Diagnosis involves skin prick tests and measuring allergen-specific IgE levels through blood tests. Repeated allergen exposure drives the sensitization process and production of more IgE antibodies in atopic individuals.
Hypersensitivity and Allergy
There are four main types of hypersensitivity reactions:
1. Type 1 is an IgE-mediated allergy involving mast cell degranulation. Common allergies include hay fever, food allergies, and more.
2. Type 2 involves IgG and IgM antibodies binding to cell surfaces and activating the complement system or phagocytes. This includes hemolytic transfusion reactions and hemolytic disease of the newborn.
3. Type 3 occurs when circulating immune complexes are deposited in tissues, activating the complement system and causing inflammation. Examples include serum sickness and some autoimmune diseases.
4. Type 4 is a delayed T cell-mediated response, like contact dermatitis and
This document discusses hypersensitivity reactions of types I and II. It defines hypersensitivity as undesirable immune responses that can cause tissue damage or death. Type I reactions are immediate and IgE-mediated, involving mast cell degranulation. Common allergens are listed. Type II reactions are antibody-mediated and cytotoxic, destroying cells through complement activation or antibody-dependent cellular cytotoxicity. Examples given include blood transfusion reactions and hemolytic disease of the newborn. The mechanisms, mediators, treatments, and tests related to types I and II hypersensitivity reactions are described in detail.
This document discusses hypersensitivity reactions of types I and II. It defines hypersensitivity as undesirable immune responses that can cause tissue damage or death. Type I reactions are immediate and IgE-mediated, involving mast cell degranulation. Common allergens are listed. Type II reactions are antibody-mediated and cytotoxic, destroying cells through complement activation or antibody-dependent cellular cytotoxicity. Examples given include blood transfusion reactions and hemolytic disease of the newborn. The mechanisms, mediators, treatments, and tests related to types I and II hypersensitivity are described in detail.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
2. Introduction
• What is hypersensitivity?
• It is excessive immune response which
leads to undesirable consequences, i.e.
tissue or organ damage/ dysfunction.
3. Hypersensivity
Reactions
Allergies Greek = altered reactivity
1906 – von Pirquet coined term: hypersensitivity
Hypersensitivity reactions – ‘over reaction’ of
the immune system to harmless environmental
antigens
4. • Hypersensitivity refers to undesirable
(damaging, discomfort-producing and
sometimes fatal) reactions produced by
the normal immune system
• Hypersensitivity reactions require a pre-
sensitized (immune) state of the host
• Hypersensitivity (Allergy): An
abnormal response to antigens.
5. Classification
Four Types of Hypersensitivity Reactions:
• Type I (Anaphylactic) Reactions
• Type II (Cytotoxic) Reactions
• Type III (Immune Complex) Reactions
• Type IV (Cell-Mediated) Reactions/Delayed
6. Four Types of Hypersensitivity Reactions:
• Type I (Anaphylactic) Reactions
• Type II (Cytotoxic) Reactions
• Type III (Immune Complex) Reactions
• Type IV (Cell-Mediated) Reactions
• Type V Stimulatory hypersensitivity
8. BASIC CONCEPTS
Hypersensitivity reactions are harmful antigen-specific immune
responses , occur when an individual who has been primed by an
innocuous antigen subsequently encounters the same antigen ,
produce tissue injury and dysfuntion.
Allergen:the antigens that give rise to immediate
hypersensitivity
Atopy:the genetic predisposition to synthesize inappropriate
levels of IgE specific for external allergens
9. Type I hypersensitivity
• IgE mediated, immediate hypersensitivity/
allergy
• Major features:
React and disappear quickly on re-
exposure to Ag
Dysfunction rather than severe tissue and
cell damage occurs
Obvious individual difference and genetic
correlation
10. 1) Characteristics
Occur and resolve quickly
Mediated by serum IgE
Systemic and regional tissue dysfuntion
Genetic predisposition
11. •Allergens are small Ags, usually
inocuous
•B cells produced IgE
• Occur within minutes of exposure
to antigen
•Anaphylactic shock: Massive drop
in blood pressure. Can be fatal in
minutes.
12. Type I Hypersensitivity
• Mechanism
– Allergen is recognized by naïve B cell
– B cell stimulated by T helper cell through IL4
– IgE specific for allergen is recognized by mast
cell
– Cross linkage of IgE on mast cells
– Mast cell degranulates
13. Increase in Atopic Allergy
• Environmental factors
– Exposure to pathogens in childhood
• Measles, HepA, tuberculosis exposure beneficial?
– Environmental pollution
• Eg. Children in Hale, East Germany
– Allergen levels
• No evidence of rise
– Dietary changes
• No evidence of effect
14. • Genetics factors and Allergies
– Cytokines and their receptors
– MHC II genes
– Other polymorphisms
15. What are mast cells and basophils?
Basophil- rare blood cell
Mast cells- found in connective tissue
Granules contain active mediators
17. Events in an allergic reaction:
First exposure
B cells produce allergen-specific IgE Ab
Tail of IgE Ab reacts with Fc receptors on
mast cells, leaving Fab’s directed away
from the cell surface
Second exposure
Allergen enters body, cross-links IgE on
mast cell in mucous membranes, skin, and
triggers release of chemicals symptoms
28. Effects of type I reactions
Systemic anaphylaxis
Respiration becomes difficult
Blood pressure drops
Smooth muscles of bladder and GI tract
contract
Bronchoconstriction
Countered by epinephrine
relaxes smooth muscles
decreases vascular permeability
improves cardiac output
31. Early phase response: short-lived,
resolve within 1 hr. Increase of
vasopermeability, smooth muscle
contraction, gland hypersecretion and
vasodilation
Late phase response: inflammation,
peak at around 5 hrs, last for several
days. Eosinophils, mast cells, basophils,
T-cells and neutrophils infiltration.
32. Early response - histamine, leukotrienes,
prostaglandins
bronchoconstriction, vasodilation,
smooth muscle contraction
Late response - IL-4, TNF-, etc.
endothelial cell adhesion
Also leukocyte migration, leukocyte
activation factors
Neutrophils (also eosinophils) cause a lot of
tissue damage
34. Allergen :
pollen、dust mite、insects etc
selectively activate CD4+Th2 cells and B cells
Allergin(IgE)and its production
IgE: mainly produced by mucosal B cells in the lamina prapria
special affinity to the same cell
IL-4 is essential to switch B cells to IgE production
High affinity receptor of the IgE on mast cell and basophil
Eosinophil
2) Components and cells in Type I hypersensitivity
35. 3 The process and mechanism of Type I hypersensitivity
1) Priming stage: last more than half a year
2) Activating stage:
Crosslinkage Enzyme reaction Degranulation of mast cell , basophil
3) Effect stage:
Immediate/early phase response: Mediated by histamine
Start within seconds
Last several hours
Late-phase response : Mediated by new-synthesized lipid mediators
Take up 8-12hours to develop
Last several days
36. 4. Skin allergy:
4. Common disease of type I hypersensitivity
1. Systemic anaphylaxis: a very dangerous syndrome
1) Anaphylactic drug allergy :penicillin
2) Anaphylactic serum allergy :
2. Respiratory allergic diseases :
1) Allergic asthma:acute response, chronic response
2) Allergic rhinitis
3. Gastrointestinal allergic diseases :
The lack of SIgA protein hydrolase Undigested protein
Allergen
37. Atopy
• Allergic rhinitis: Hay fever, airborn
allergens, symptoms include shedding
tears, sneezing, coughing, etc.
• Asthma: airborn/blood-born allergens.
Occur in lower respiratory tract
Cardinal clinic and physiological
features: variable airflow obstruction,
bronchial hyper-responsiveness.
40. DIAGNOSTIC TESTS FOR IMMEDIATE
HYPERSENSITIVITY INCLUDE
• skin (prick and intradermal) tests
• measurement of total IgE and specific IgE
antibodies against the suspected allergens
• Total IgE and specific IgE antibodies are
measured by a modification of enzyme
immunoassay (ELISA)
• Increased IgE levels are indicative of
an atopic condition, although IgE may be
elevated in some non-atopic diseases (e.g.,
myelomas, helminthic infection, etc.)
44. 5. Therapy of type I hypersensitivity
1. Allergen avoidance : Atopy patch test
2. Desensitivity therapy / Hyposensitization :
1) Allogenic serum desensitivity therapy:
2) Specific allergen desensitivity therapy
Repeated injection small amounts of allergen, Temporality
IgG+allergen Neutralizing antibody, Blocking antibody
3. Drug therapy:
1) Stabilization of triggering cells
sodium cromoglycate stabilize the membrane, inhibit mast cell degranulation
2) Mediator antagonism
Chlor-Trimeton Antihistamine
Acetylsalicylic acid Bradykinin antagonism
3) Improve the responsibility of target organs
4. New immunotherapy :
45. TYPE II (CYTOTOXIC) REACTIONS
– Involve activation of complement by IgG or IgM
binding to an antigenic cell.
– Antigenic cell is lysed.
– Transfusion reactions:
46. • Mediated by IgG and/or IgM
• Mechanism:
Ag present on the surface of cells→ im-
munity activation→Ab→tissue damage/
dysfunction
Tissue damage caused by:
Opsonic adherence: phagocytosis
Complement: membrane damage
ADCC: cell destruction
Type II hypersensitivity
50. Type II associated diseases
• Transfusion reaction: mismatched blood
transfusion cause complement-mediated
hemolysis.
ABO blood group: isohemagglutinins(IgM)
Prevention: cross-matching between
donor and recipient blood
51. Heamolytic diseases of newborn
• Rh incompatibility: Rh blood groups
Rh- mother has the first Rh+ baby→
mother sensitized by baby’s erythrocy-tes
→anti-Rh IgG
Mother has the second Rh+ baby→ IgG
enter the fetus through placenta→
destruction of fetal RBC
55. Grave’s disease and myasthenia
gravis
• Special class of type V hypersensitivity,
Autoimmune diseases, tissue/organ
dysfunction
• Grave’s disease: anti-TSH receptor
• Myasthenia gravis: anti-acetylcholine
receptors
58. 2. Mechanism of Type II hypersentivity
1. Surface antigen on target cells
Target cells: Normal tissue cell, changed or modified self tissue cells
2. Antibody, complement and modified self-cell
Antigen : Blood group antigen, Common antigen,
Self-antigen modified by physical factors or infection
Drug antigen,
Antigen-antibody complex
Activate complement Lyse target cells
Opsonic phogacytosis Destroy target cells
ADCC
Mf、NK、 T
Stimulating or blocking effect Promote /surpress the target cell funcion
59. Antigen or hapten on cell
Antibody (IgG, IgM)
Activate complement
Lyse target cell
Opsonic phagocytosis NK , phagocyte Stimulate / block
Destroy target cell ADCC
Target cell injury Change the function ofTarget cell
Mechanism of Type II hypersensitivity
60. 3. Common disease of type II hypersensitivity
1)Transfusion reaction
hemolysis : mismatch of ABO blood group, severely destroy RBC
nonhemolysis : repeat transfusion of allogenic HLA
drug anaphylactic shock:penicilline
2) Hemolytic disease of newborn
Mother Rh- : first baby Rh+(Ab), second baby Rh+,
fetal RBC destroyed
3) Autoimmune hemolytic anemia and type II drug reaction
i. Foreign antigen or hapten
Penicillin RBC hemolytic anemia
Quinin Platlet thrombocytopenic purpura
Pyramidone Granulocyte agranulocytosis
ii. Self-antigen
Drug conversion from a hapten to a full antigen
induce self antibody autoimmune hemolytic anemia
61. 4.Anti -glomerular basement membrane nephritis
β-Hemolytic streptococcus and human glomerular basement membrane
----
cross
reaction
Common antigen ---nephrotoxic nephritis
5. Super acute rejection in allogenic organ
transplantation
6. Goodpasture syndrome
7.Hyperthyroidism or hypothyroidism—receptor
diseases
62. • Diagnostic tests include detection
of circulating antibody against the
tissues involved and the
presence of antibody and
complement in the lesion (biopsy)
by immunofluorescence.
65. Typical diseases of
anaphylaxis
• Systemic anaphylaxis(anaphylactic
shock): fatal, venom from bee, wasp;
drugs such as penicillin, antitoxins, etc.
• Localized anaphylaxis(atopy): the tend-
ency to manifest localized anaphylaxis is
inherited and called atopy. typical
diseases: asthma, hayfever, eczema,
food allergy, etc.
66. • Mediated by IgG and/or IgM
• Mechanism:
Ag present on the surface of cells→ im-
munity activation→Ab→tissue damage/
dysfunction
Tissue damage caused by:
Opsonic adherence: phagocytosis
Complement: membrane damage
ADCC: cell destruction
Type II hypersensitivity
67. Type II associated diseases
• Transfusion reaction: mismatched blood
transfusion cause complement-mediated
hemolysis.
ABO blood group: isohemagglutinins(IgM)
Prevention: cross-matching between
donor and recipient blood